In particular, the very pronounced increase of FABP4 at the RNA and protein levels in both tumor cells and tumor stroma is a strong indicator of the validity of the hypothesis that the prognostic effect of SARIFA is driven by metabolic reprogramming1,7,18. The gene discussed is FABP4; the disease is neoplasm.